Skip to main content
. 2023 Aug 25;14(9):441. doi: 10.3390/jfb14090441

Table 1.

Synthetic Mir210 and other oligonucleotides used in this work.

Aptamer Oligonucleotides (5′-3′) Used
Mir210 CUGUGCGUGUGACAGCGGCUGA
Mir210 cDNA GACACGCACACTGTCGCCGACT
Reverse complement FAM-TCAGCCGCTGTCACACGCACAG
Anti-CEA Aptamer H2NTCGCGCGAGTCGTCTGGGGAACCATCGAGTTACACCGACCTTCTATGTGCGGCCCCCCGCATCGTCCTCCC
Reverse complementary of CEA aptamer GGGAGGACGATGCGGGGGGCCGCACATAGAAGGTCGGTGTAACTCGATGGTTCCCCAGACGACTCGCGCGA